Seminars in Oncology Nursing
Volume 23, Supplement 1 , Pages 22-35, February 2007

Nursing Care of Patients Receiving Chemotherapy for Metastatic Colorectal Cancer: Implications of the Treatment Continuum Concept

Department of Physiological Nursing, University of California, San Francisco, San Francisco, CA and the Department of Gastrointestinal Oncology, Dana-Farber Cancer Institute, Boston, MA

Objectives

To discuss oncology nurses’ roles in the treatment of metastatic colorectal cancer (mCRC) and review the toxicities and nursing management strategies for chemotherapy agents and targeted therapies.

Data Sources

Current research, clinical literature, and Internet sources.

Conclusion

Knowledge of the current therapies approved in the treatment of mCRC is essential in the care of diagnosed patients. Comprehensive assessment and management of associated toxicities of therapy is integral to patient care.

Implications for Nursing Practice

Oncology nurses have important roles in assessing patients for appropriate therapy and providing timely interventions, which may reduce therapy-associated toxicities and maximize treatment efficacy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(06)00113-6

doi:10.1016/j.soncn.2006.08.003

Seminars in Oncology Nursing
Volume 23, Supplement 1 , Pages 22-35, February 2007

Article Tools